# OnCo record pazopanib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/pazopanib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "pazopanib" ;
  schema:name "Pazopanib"@en ;
  schema:description "Pazopanib is the only multi-kinase inhibitor approved for soft-tissue sarcoma (excluding fat-derived tumours), used after chemotherapy fails."@en ;
  schema:url <https://onco.cc/drugs/pazopanib/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Pazopanib> ;
  owl:sameAs <http://www.wikidata.org/entity/Q7157043> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pazopanib> ;
  onco:status "approved" ;
  onco:modality "Small-molecule kinase inhibitor (VEGFR/PDGFR/KIT)" ;
  schema:alternateName "Votrient" ;
  onco:approval "US 2009: Advanced renal cell carcinoma", "US 2012: Advanced non-adipocytic soft-tissue sarcoma after chemotherapy" ;
  onco:cancers <https://onco.cc/cancers/sarcoma/>, <https://onco.cc/cancers/rcc/>, <https://onco.cc/cancers/angiosarcoma/>, <https://onco.cc/cancers/alveolar-soft-part-sarcoma/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/antiangiogenic/> ;
  onco:targets <https://onco.cc/targets/vegf/>, <https://onco.cc/targets/kit/> ;
  onco:companies <https://onco.cc/companies/novartis/> ;
  onco:trials <https://onco.cc/trials/nct07087158/> .